Wed, February 5, 2020
Tue, February 4, 2020
Mon, February 3, 2020
Fri, January 31, 2020
Thu, January 30, 2020
Wed, January 29, 2020
Tue, January 28, 2020

Kevin Huang Maintained (VRTX) at Strong Buy with Increased Target to $286 on, Jan 31st, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-286-on-jan-31st-2020.html
  Print publication without navigation Published in Stocks and Investing on by
          🞛 This publication is a summary or evaluation of another publication

Kevin Huang of CFRA, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $237 to $286 on, Jan 31st, 2020.

Kevin has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Kevin's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Kevin


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $265 on, Wednesday, January 8th, 2020
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $284 on, Monday, January 6th, 2020
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019